01.31.2025
Animal Health Insights Series (2/4) - Why is Animal Health is attractive to investors?
The Animal Health industry is considered attractive due to its forecasted growth of 3.1% between 2025 and 2030, driven by rapidly expanding product groups such as:
- Companion Animal Therapeutics ('25-'30 CAGR: 4.9% )
- Companion Animal Parasiticides ('25-'30 CAGR: 3.7%)
- Poultry Vaccine ('25-'30 CAGR: 3.4%)
Stonehaven Cozmix Group has collaborated with Duncan Mackintosh (Brandon Capital Senior Investment Manager, Cadmus Animal Health Exec Chair) and Rana Ali (Brandon Capital Portfolio Manager, Cadmus Animal Health COO) on a report exploring the attractiveness of the Animal Health industry and its thriving start-up ecosystem. Stay tuned for more insights!
Highlights from the report will be shared at the exclusive Start-up & Investor Reception on February 10th during the Animal Health, Nutrition & Technology Innovation Europe conference in London.Want to know more about this exciting sector? Read on! #VeterinaryCare #AnimalHealth #Consulting #Investing
Contact Us
Matthias Hofer
Managing Partner
Jürg Baggenstoss
Partner
Katja Glauser
Engagement
Manager
Contact Us
Matthias Hofer
Managing Partner
Jürg Baggenstoss
Partner
Katja Glauser
Engagement
Manager
Related Articles
Kansas City Summit Investor Panel
We’re thrilled to share that our CEO & Managing Partner, Matthias Hofer, will be moderating the “How Animal Health Innovators Can Fund, Partner and Scale” investor panel at the Animal Health Corridor Summit 2026.
Stonehaven Cozmix July Promotions
We are delighted to announce four well-deserved promotions within our consulting team
Interview with Fabian Kausche
In our latest Leaders in Animal Health interview, Fabian reflects on a remarkable journey that has taken him from veterinary student
